193 related articles for article (PubMed ID: 19763141)
1. mtDNA G10398A variant in African-American women with breast cancer provides resistance to apoptosis and promotes metastasis in mice.
Kulawiec M; Owens KM; Singh KK
J Hum Genet; 2009 Nov; 54(11):647-54. PubMed ID: 19763141
[TBL] [Abstract][Full Text] [Related]
2. Cancer cell mitochondria confer apoptosis resistance and promote metastasis.
Kulawiec M; Owens KM; Singh KK
Cancer Biol Ther; 2009 Jul; 8(14):1378-85. PubMed ID: 19556849
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women.
Canter JA; Kallianpur AR; Parl FF; Millikan RC
Cancer Res; 2005 Sep; 65(17):8028-33. PubMed ID: 16140977
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial DNA G10398A variant is not associated with breast cancer in African-American women.
Setiawan VW; Chu LH; John EM; Ding YC; Ingles SA; Bernstein L; Press MF; Ursin G; Haiman CA; Neuhausen SL
Cancer Genet Cytogenet; 2008 Feb; 181(1):16-9. PubMed ID: 18262047
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial DNA G10398A polymorphism imparts maternal Haplogroup N a risk for breast and esophageal cancer.
Darvishi K; Sharma S; Bhat AK; Rai E; Bamezai RN
Cancer Lett; 2007 May; 249(2):249-55. PubMed ID: 17081685
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of mitochondrial DNA content and G10398A polymorphism in non-small cell lung cancer.
Xu H; He W; Jiang HG; Zhao H; Peng XH; Wei YH; Wei JN; Xie CH; Liang C; Zhong YH; Zhang G; Deng D; Zhou YF; Zhou FX
Oncol Rep; 2013 Dec; 30(6):3006-12. PubMed ID: 24101028
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial DNA depletion promotes impaired oxidative status and adaptive resistance to apoptosis in T47D breast cancer cells.
Yu M; Shi Y; Wei X; Yang Y; Zang F; Niu R
Eur J Cancer Prev; 2009 Nov; 18(6):445-57. PubMed ID: 19609211
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk from non-cancerous mitochondria can inhibit tumor properties of metastatic cells by suppressing oncogenic pathways.
Kaipparettu BA; Ma Y; Park JH; Lee TL; Zhang Y; Yotnda P; Creighton CJ; Chan WY; Wong LJ
PLoS One; 2013; 8(5):e61747. PubMed ID: 23671572
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer-associated mitochondrial DNA haplogroup promotes neoplastic growth via ROS-mediated AKT activation.
Ma L; Fu Q; Xu B; Zhou H; Gao J; Shao X; Xiong J; Gu Q; Wen S; Li F; Shen L; Chen G; Fang H; Lyu J
Int J Cancer; 2018 May; 142(9):1786-1796. PubMed ID: 29226320
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis inhibitor ARC promotes breast tumorigenesis, metastasis, and chemoresistance.
Medina-Ramirez CM; Goswami S; Smirnova T; Bamira D; Benson B; Ferrick N; Segall J; Pollard JW; Kitsis RN
Cancer Res; 2011 Dec; 71(24):7705-15. PubMed ID: 22037876
[TBL] [Abstract][Full Text] [Related]
11. A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis.
Park JS; Sharma LK; Li H; Xiang R; Holstein D; Wu J; Lechleiter J; Naylor SL; Deng JJ; Lu J; Bai Y
Hum Mol Genet; 2009 May; 18(9):1578-89. PubMed ID: 19208652
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women.
Mims MP; Hayes TG; Zheng S; Leal SM; Frolov A; Ittmann MM; Wheeler TM; Prchal JT
Cancer Res; 2006 Feb; 66(3):1880; author reply 1880-1. PubMed ID: 16452251
[No Abstract] [Full Text] [Related]
13. Mitochondrial ND3 G10398A mutation: a biomarker for breast cancer.
Yu Y; Lv F; Lin H; Qian G; Jiang YS; Pang LX; Wang YP; Wang XF; Kang YM; Li CB; Liu Q; Xu JZ; You W
Genet Mol Res; 2015 Dec; 14(4):17426-31. PubMed ID: 26782384
[TBL] [Abstract][Full Text] [Related]
14. An association analysis between mitochondrial DNA content, G10398A polymorphism, HPV infection, and the prognosis of cervical cancer in the Chinese Han population.
Feng D; Xu H; Li X; Wei Y; Jiang H; Xu H; Luo A; Zhou F
Tumour Biol; 2016 Apr; 37(4):5599-607. PubMed ID: 26577855
[TBL] [Abstract][Full Text] [Related]
15. Does mitochondrial DNA play a role in Parkinson's disease? A review of cybrid and other supportive evidence.
Swerdlow RH
Antioxid Redox Signal; 2012 May; 16(9):950-64. PubMed ID: 21338319
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial DNA variants as genetic risk factors for Parkinson disease.
Liou CW; Chuang JH; Chen JB; Tiao MM; Wang PW; Huang ST; Huang TL; Lee WC; Weng SW; Huang PH; Chen SD; Chen RS; Lu CS; Lin TK
Eur J Neurol; 2016 Aug; 23(8):1289-300. PubMed ID: 27160373
[TBL] [Abstract][Full Text] [Related]
17. Loss of mutant mitochondrial DNA harboring the MELAS A3243G mutation in human cybrid cells after cell-cell fusion with normal tissue-derived fibroblast cells.
Yano T; Tanaka M; Fukuda N; Ueda T; Nagase H
Int J Mol Med; 2010 Jan; 25(1):153-8. PubMed ID: 19956914
[TBL] [Abstract][Full Text] [Related]
18. mtDNA germ line variation mediated ROS generates retrograde signaling and induces pro-cancerous metabolic features.
Singh RK; Srivastava A; Kalaiarasan P; Manvati S; Chopra R; Bamezai RN
Sci Rep; 2014 Oct; 4():6571. PubMed ID: 25300428
[TBL] [Abstract][Full Text] [Related]
19. Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.
Dey JH; Bianchi F; Voshol J; Bonenfant D; Oakeley EJ; Hynes NE
Cancer Res; 2010 May; 70(10):4151-62. PubMed ID: 20460524
[TBL] [Abstract][Full Text] [Related]
20. Activation of p21(CIP1/WAF1) in mammary epithelium accelerates mammary tumorigenesis and promotes lung metastasis.
Cheng X; Xia W; Yang JY; Hsu JL; Chou CK; Sun HL; Wyszomierski SL; Mills GB; Muller WJ; Yu D; Hung MC
Biochem Biophys Res Commun; 2010 Dec; 403(1):103-7. PubMed ID: 21040707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
